KP Tissue Received its Third Buy in a Row

By Jason Carr

Analysts seem to be optimistic about KP Tissue (TSX: KPT) lately with another positive rating update this time from RBC Capital. RBC Capital’s analyst Paul Quinn reiterates their Buy rating on the shares today.

According to, Quinn is a top 100 analyst with an average return of 17.9% and a 74.0% success rate. Quinn covers the Consumer Goods sector, focusing on stocks such as Mercer International Inc, International Paper Co, and Meadwestvaco Corp.

KP Tissue has an analyst consensus of Strong Buy, with a price target consensus of C$17.25.

The company has a one year high of C$16.34 and a one year low of C$10.94. Currently, KP Tissue has an average volume of 12.45K.

KP Tissue, Inc. operates as a holding company. The company produces, distributes, markets and sells disposable tissue products, such as bathroom tissue, facial tissue and paper towels for both the consumer and away-from-home markets. KP Tissue was founded in October 2012 and is headquartered in Mississauga, Canada.

The company’s shares closed last Tuesday at $15.13.